• Stock jumps 11.31% to ₹361.11, extending sharp rebound phase
  • Net profit at ₹1,246.46 lakh supports steady earnings base
  • RSI near overbought zone, momentum strong but slightly stretched

Overview

Gujarat Themis Biosyn (NSE: GUJTHEM) moved higher to ₹361.11, gaining 11.31% and continuing its sharp recovery from recent lows. The stock has seen a strong shift in price structure, transitioning from a corrective phase into a rebound-driven trend.

The latest move reflects improving short-term sentiment, with price action pushing toward a key resistance band. While the rally is gaining traction, the stock is now entering levels where supply could start to emerge.

Fundamental View

For the quarter ended December 2025, the company reported total income of ₹4,378.44 lakh. Profit before tax stood at ₹1,687.34 lakh, while net profit came in at ₹1,246.46 lakh. Earnings per share was ₹1.14.

The company continues to maintain a stable profitability profile within the pharma and fermentation segment. However, the stock trades at relatively elevated valuation multiples, which may limit aggressive upside unless earnings expansion sustains.

Technical View

Technically, GUJTHEM has shown a strong recovery after forming a base near recent lows. The stock has moved above its recent consolidation range, indicating improving structure.

The latest candle reflects a bullish expansion, suggesting momentum is still active. At the same time, RSI is around 71.68, entering overbought territory, which indicates that the rally is getting stretched in the near term.

While the trend is improving, some consolidation or pause cannot be ruled out near current levels.

Key Technical Levels

The stock is approaching a support zone of ₹310.50–₹285.50, which may act as a cushion on any pullback. Holding above this zone will keep the recovery structure intact.

On the upside, resistance is placed at ₹400.50–₹425.90, where the stock may face supply pressure.

Source: TradingView

Risks To Watch

• Overbought RSI indicating short-term cooling risk
  • Elevated valuation relative to earnings
  • Volatility near resistance zone
  • Momentum-driven rally without fresh triggers

Summary

Gujarat Themis Biosyn has delivered a strong recovery, supported by stable earnings and improving technical structure. However, with RSI in overbought territory and resistance approaching, the stock may enter a consolidation phase before the next directional move.

FAQs

What is the correct ticker for Gujarat Themis Biosyn?
The correct ticker is NSE: GUJTHEM.

Why is the stock rising?
The rally is driven mainly by technical recovery and improving short-term momentum.

What levels should traders watch?
Support is at ₹310.50–₹285.50, while resistance is at ₹400.50–₹425.90.